Search

everythinglearnresearchcommunity

for

Search:↓

Tyrosine kinases are important in skin autoimmune diseases and could be targets for new treatments.

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

New treatments like nanotechnology show promise in improving skin cancer therapy.

Scientists made a mouse model of a serious skin cancer by changing skin cells with a virus and a specific gene, which is similar to the disease in humans.

GLI1 might protect against the start of skin cancer and is not linked to cancer severity.

Combining PRP with Minoxidil improves hair density and thickness more than Minoxidil alone.

CRISPR/Cas9 has improved precision and control but still faces clinical challenges.

MJ04, a new compound, effectively promotes hair growth and is a potential topical treatment for hair loss.

Loss of the Y chromosome and UTY gene activity increases cancer risk in men.

Enzymatic synthesis improved the water solubility of the flavonoid baicalin, which may help treat hair loss conditions.

Platelet-rich plasma treatment is more effective and cost-efficient than epinephrine for healing bleeding peptic ulcers, with fewer complications and rebleeding cases.

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

Giving docetaxel weekly at 40 mg/m² is manageable and has low toxicity for cancer patients.

A woman's small, unnoticed adrenal mass turned out to be a rare non-Hodgkin's lymphoma, treated successfully with surgery and therapy.

Blood stem cells are diverse, influenced by many factors, and understanding them is key for progress in regenerative medicine.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

Most pediatric cancer patients at Muhimbili National Hospital in Tanzania experienced side effects from chemotherapy, with nausea, hair loss, and low white blood cell count being the most common.

Platelet Rich Plasma (PRP) injections can improve hair count, thickness, and strength in people with androgenic alopecia.

Iron deficiency may contribute to hair loss.

Scalp cooling can prevent hair loss in 65% of chemotherapy patients, especially effective in breast cancer patients and certain chemotherapy types.

YAP and TAZ proteins are necessary for the development of two types of skin cancer.

Cancer can hijack the body's cell repair system to promote tumor growth, and targeting this process may improve cancer treatments.

Endocrine therapies for cancer significantly increase the risk of hair loss.

The conclusion is that effective cancer treatment often requires a combination of therapies, but must be carefully managed due to serious side effects and the risk of immunosuppression.

Changing the environment around stem cells could help tissue repair, but it's hard to be precise and avoid side effects.

Using hair dye may slightly increase the risk of non-Hodgkin's lymphoma, especially with long-term use.

A woman with a rare scalp lymphoma had unusual hair loss after treatment.

A Japanese bone marrow transplant patient developed a rare skin cancer possibly linked to long-term use of the medication voriconazole.

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.